Point-of-care testing: physician's office and other alternative site testing
This article was originally published in Clinica
Executive Summary
The market for physician's office laboratory (POL) testing covers a wide range of product segments, including chemistry, immunochemistry, haematology, infectious disease, urinalysis, allergy and diabetes. The market is mature, since the number of labs worldwide is not growing rapidly and patient load is also relatively stable. The customer base ranges from small labs that primarily perform simple tests which do not require the skills of a laboratory technician (CLIA-waived tests or provider-performed microscopy procedures in the US), to large operations serving group practices that are equivalent to some hospital-based labs in terms of equipment and test volume. Market data is most extensive in the US, which accounts for the majority of POLs as well as most of the POL products marketed worldwide.
You may also be interested in...
The clinical diagnostics market – the rest of the world
Sales in the clinical diagnostics market in the rest of world region, which in this analysis includes China and India, totalled $5.4bn in 2010. The market is forecast to grow at 9.9% per year over the 2010-2015 interval. In the ROW region, growth will be driven by rapid adoption of new technologies and increasing utilisation of healthcare resources in developing countries in Asia (particularly China and India) and, to a lesser extent, in Latin America.
The European clinical diagnostics market – Italy and the UK
Italy is the third-largest clinical diagnostics country market in Europe, with a total market size only slightly smaller than that of France. Italy devoted 9.6% of its gross domestic product (GDP) to healthcare expenditures in 2010, up from 8.7% in 2007, according to statistics from the Organization for Economic Cooperation and Development. This is higher than in the late 1990s and early 2000s, although spending as a percentage of GDP dropped as low as 7.4% in 1995, similar to rates in the UK and Spain.
The European clinical diagnostics market – Germany and France
Germany and France are the number-one and -two markets in Europe for clinical diagnostics products, respectively, each with their own unique characteristics and challenges.